Researchers and opinion leaders have considered a number of potential solutions to the so-called antibody-related reproducibility “crisis”. One is to transition from traditional monoclonal antibodies to recombinant antibodies*. So, what makes recombinant antibodies better and more effective than conventional hybridoma-derived antibodies? In this video, six experts from the flow cytometry and antibody community share their opinion and experience with recombinant antibodies.
Watch Video